EurekAlert!3d
Thirty-three centers join new Bronchiectasis and NTM Care Center Network
The Bronchiectasis and NTM Association has accepted 27 Care Center and six Clinical Associate Center sites in 23 states and the District of Columbia into the new Bronchiectasis and NTM Care Center ...
University of California, San Francisco3d
UCSF Among First in U.S. to Receive New Pulmonary Care Designation
The Bronchiectasis and NTM Association has accepted UC San Francisco (UCSF) into its Bronchiectasis and NTM Care Center Network (CCN), recognizing UCSF’s dedication to providing high-quality medical ...
Healio3d
25.4% of patients with bronchiectasis had symptoms for more than 10 years before diagnosis
Prior to being diagnosed with bronchiectasis, many patients reported living with symptoms for multiple years, according to ...
Medical Dialogues3d
Colistimethate sodium effective against bronchiectasis and P. aeruginosa infection: Study
According to PROMIS-I data published in the journal of The Lancet Respiratory Medicine showed that individuals with ...
The Cardiology Advisor11d
In Bronchiectasis, Macrolide Maintenance Therapy Reduces Cardiovascular Events
Macrolide maintenance therapy in patients with bronchiectasis significantly reduces the risk for major adverse cardiovascular events.
Verona Pharma plc: Verona Pharma Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
OhtuvayreTM (ensifentrine) recorded net product sales of $36.6 million in Q4 and $42.3 million in 2024 More prescriptions filled through February 2025 than in Q4 2024 Over 4,600 unique prescribers wit ...
Insmed Announces FDA Not Holding Advisory Committee Meeting for Brensocatib NDA
Insmed Incorporated (NASDAQ: INSM) announced on February 24, 2025 that the U.S. Food and Drug Administration (FDA) does not currently plan to hold an advisory committee meeting to discuss the ...
Frontiers18d
Impact of physical activity on all-cause mortality in individuals with non-cystic fibrosis bronchiectasis
Background: Little information is available regarding whether active physical activity lowers mortality risk in individuals with bronchiectasis. Methods: We used the Korean National Health Insurance ...
Investing18d
FDA sets PDUFA date for Insmed's bronchiectasis drug
This Phase 3 study is the largest ever conducted for bronchiectasis, a chronic lung condition characterized by the widening of the airways, leading to recurrent infections, inflammation ...
Business Wire18d
AN2 Provides Strategic Update for Phase 3 EBO-301 Trial in Treatment Refractory MAC Lung Disease
today announced its submission of an amended statistical analysis plan to the FDA selecting the Quality of Life – Bronchiectasis (QOL-B) respiratory domain patient reported outcome (PRO ...
interaksyon.philstar22d
Explainer: Pope Francis has double pneumonia – what does that mean?
He developed pneumonia after being hospitalized last week for a respiratory infection on top of two other airway conditions, bronchiectasis and asthmatic bronchitis, a Vatican statement said on ...
Pope Francis’ medical condition: What to know about bilateral pneumonia
Following Pope Francis’ diagnosis of bilateral pneumonia, respiratory doctors are speaking about the condition. The Vatican announced the Catholic leader’s diagnosis this week.